vs

Side-by-side financial comparison of MAXLINEAR, INC (MXL) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $137.2M, roughly 1.6× MAXLINEAR, INC). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 5.8% vs -32.9%, a 38.7% gap on every dollar of revenue. On growth, MAXLINEAR, INC posted the faster year-over-year revenue change (43.0% vs 9.6%). Over the past eight quarters, MAXLINEAR, INC's revenue compounded faster (22.1% CAGR vs 9.5%).

MaxLinear, Inc. is an American electronic hardware company. Founded in 2003, it provides highly integrated radio-frequency (RF) analog and mixed-signal semiconductor products for broadband communications applications. It is a New York Stock Exchange-traded company.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

MXL vs UTI — Head-to-Head

Bigger by revenue
UTI
UTI
1.6× larger
UTI
$220.8M
$137.2M
MXL
Growing faster (revenue YoY)
MXL
MXL
+33.4% gap
MXL
43.0%
9.6%
UTI
Higher net margin
UTI
UTI
38.7% more per $
UTI
5.8%
-32.9%
MXL
Faster 2-yr revenue CAGR
MXL
MXL
Annualised
MXL
22.1%
9.5%
UTI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
MXL
MXL
UTI
UTI
Revenue
$137.2M
$220.8M
Net Profit
$-45.1M
$12.8M
Gross Margin
57.5%
Operating Margin
30.0%
7.1%
Net Margin
-32.9%
5.8%
Revenue YoY
43.0%
9.6%
Net Profit YoY
-203.0%
-42.1%
EPS (diluted)
$-0.52
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MXL
MXL
UTI
UTI
Q1 26
$137.2M
Q4 25
$136.4M
$220.8M
Q3 25
$126.5M
$222.4M
Q2 25
$108.8M
$204.3M
Q1 25
$95.9M
$207.4M
Q4 24
$92.2M
$201.4M
Q3 24
$81.1M
$196.4M
Q2 24
$92.0M
$177.5M
Net Profit
MXL
MXL
UTI
UTI
Q1 26
$-45.1M
Q4 25
$-14.9M
$12.8M
Q3 25
$-45.5M
$18.8M
Q2 25
$-26.6M
$10.7M
Q1 25
$-49.7M
$11.4M
Q4 24
$-57.8M
$22.2M
Q3 24
$-75.8M
$18.8M
Q2 24
$-39.3M
$5.0M
Gross Margin
MXL
MXL
UTI
UTI
Q1 26
57.5%
Q4 25
57.6%
Q3 25
56.9%
Q2 25
56.5%
Q1 25
56.1%
Q4 24
55.6%
Q3 24
54.4%
Q2 24
54.6%
Operating Margin
MXL
MXL
UTI
UTI
Q1 26
30.0%
Q4 25
-10.9%
7.1%
Q3 25
-32.7%
11.2%
Q2 25
-22.6%
6.9%
Q1 25
-48.0%
8.1%
Q4 24
-44.7%
13.6%
Q3 24
-82.3%
13.3%
Q2 24
-44.4%
4.2%
Net Margin
MXL
MXL
UTI
UTI
Q1 26
-32.9%
Q4 25
-10.9%
5.8%
Q3 25
-36.0%
8.4%
Q2 25
-24.4%
5.2%
Q1 25
-51.8%
5.5%
Q4 24
-62.8%
11.0%
Q3 24
-93.4%
9.6%
Q2 24
-42.7%
2.8%
EPS (diluted)
MXL
MXL
UTI
UTI
Q1 26
$-0.52
Q4 25
$-0.17
$0.23
Q3 25
$-0.52
$0.33
Q2 25
$-0.31
$0.19
Q1 25
$-0.58
$0.21
Q4 24
$-0.68
$0.40
Q3 24
$-0.90
$0.35
Q2 24
$-0.47
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MXL
MXL
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$61.1M
$162.8M
Total DebtLower is stronger
$123.8M
$101.4M
Stockholders' EquityBook value
$454.2M
$335.9M
Total Assets
$771.3M
$834.0M
Debt / EquityLower = less leverage
0.27×
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MXL
MXL
UTI
UTI
Q1 26
$61.1M
Q4 25
$72.8M
$162.8M
Q3 25
$111.9M
$169.1M
Q2 25
$108.6M
$70.7M
Q1 25
$102.8M
$96.0M
Q4 24
$118.6M
$172.0M
Q3 24
$148.5M
$161.9M
Q2 24
$185.1M
$115.5M
Total Debt
MXL
MXL
UTI
UTI
Q1 26
$123.8M
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Stockholders' Equity
MXL
MXL
UTI
UTI
Q1 26
$454.2M
Q4 25
$451.9M
$335.9M
Q3 25
$464.7M
$328.1M
Q2 25
$488.3M
$306.8M
Q1 25
$493.2M
$293.9M
Q4 24
$516.3M
$280.0M
Q3 24
$556.9M
$260.2M
Q2 24
$617.3M
$239.4M
Total Assets
MXL
MXL
UTI
UTI
Q1 26
$771.3M
Q4 25
$796.4M
$834.0M
Q3 25
$808.1M
$826.1M
Q2 25
$863.7M
$740.8M
Q1 25
$855.3M
$720.4M
Q4 24
$864.6M
$753.8M
Q3 24
$895.3M
$744.6M
Q2 24
$973.2M
$706.0M
Debt / Equity
MXL
MXL
UTI
UTI
Q1 26
0.27×
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MXL
MXL
UTI
UTI
Operating Cash FlowLast quarter
$3.1M
Free Cash FlowOCF − Capex
$-19.2M
FCF MarginFCF / Revenue
-8.7%
Capex IntensityCapex / Revenue
10.1%
Cash ConversionOCF / Net Profit
0.24×
TTM Free Cash FlowTrailing 4 quarters
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MXL
MXL
UTI
UTI
Q1 26
Q4 25
$10.4M
$3.1M
Q3 25
$10.1M
$57.1M
Q2 25
$10.5M
$18.1M
Q1 25
$-11.4M
$-789.0K
Q4 24
$-27.8M
$23.0M
Q3 24
$-30.7M
$67.5M
Q2 24
$-2.7M
$10.0M
Free Cash Flow
MXL
MXL
UTI
UTI
Q1 26
Q4 25
$6.7M
$-19.2M
Q3 25
$4.4M
$40.6M
Q2 25
$9.3M
$6.8M
Q1 25
$-13.4M
$-11.7M
Q4 24
$-30.0M
$19.6M
Q3 24
$-34.9M
$60.0M
Q2 24
$-5.7M
$3.0M
FCF Margin
MXL
MXL
UTI
UTI
Q1 26
Q4 25
4.9%
-8.7%
Q3 25
3.5%
18.3%
Q2 25
8.6%
3.4%
Q1 25
-14.0%
-5.7%
Q4 24
-32.6%
9.7%
Q3 24
-43.0%
30.6%
Q2 24
-6.2%
1.7%
Capex Intensity
MXL
MXL
UTI
UTI
Q1 26
Q4 25
2.7%
10.1%
Q3 25
4.5%
7.4%
Q2 25
1.1%
5.5%
Q1 25
2.1%
5.3%
Q4 24
2.4%
1.7%
Q3 24
5.1%
3.8%
Q2 24
3.3%
4.0%
Cash Conversion
MXL
MXL
UTI
UTI
Q1 26
Q4 25
0.24×
Q3 25
3.04×
Q2 25
1.69×
Q1 25
-0.07×
Q4 24
1.04×
Q3 24
3.58×
Q2 24
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MXL
MXL

Segment breakdown not available.

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons